ALLIANCEBERNSTEIN L.P. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$95,095,000
+799.2%
2,052,554
+373.2%
0.06%
+742.9%
Q1 2019$10,575,000
+17.5%
433,749
-31.3%
0.01%0.0%
Q4 2018$8,997,000
-13.3%
631,349
-7.5%
0.01%0.0%
Q3 2018$10,378,000
+42.9%
682,749
+57.8%
0.01%
+40.0%
Q2 2018$7,262,000
+3.1%
432,749
+0.2%
0.01%0.0%
Q1 2018$7,047,000
+52.2%
431,809
+19.3%
0.01%
+66.7%
Q4 2017$4,631,000
+46.6%
361,829
+40.9%
0.00%
+50.0%
Q3 2017$3,159,000
+46.9%
256,8290.0%0.00%0.0%
Q2 2017$2,150,000
-26.2%
256,829
-21.2%
0.00%0.0%
Q1 2017$2,912,000
+46.6%
325,779
+44.2%
0.00%0.0%
Q4 2016$1,986,000
+48.3%
225,929
+13.9%
0.00%
+100.0%
Q3 2016$1,339,000
+89.7%
198,3290.0%0.00%0.0%
Q2 2016$706,000
+20.7%
198,3290.0%0.00%
Q1 2016$585,000
-35.4%
198,329
-7.5%
0.00%
-100.0%
Q4 2015$905,000
-7.5%
214,4290.0%0.00%0.0%
Q3 2015$978,000
-36.8%
214,429
-0.1%
0.00%0.0%
Q2 2015$1,548,000
+5.7%
214,719
+8.1%
0.00%0.0%
Q1 2015$1,464,000
+52.0%
198,619
-2.4%
0.00%0.0%
Q4 2014$963,000
+32.5%
203,5190.0%0.00%0.0%
Q3 2014$727,000
-22.7%
203,519
-1.2%
0.00%0.0%
Q2 2014$940,000
-3.0%
206,0930.0%0.00%0.0%
Q1 2014$969,000
-6.2%
206,0930.0%0.00%0.0%
Q4 2013$1,033,000
-19.4%
206,093
-0.0%
0.00%0.0%
Q3 2013$1,282,000
+36.1%
206,131
-0.6%
0.00%0.0%
Q2 2013$942,000207,4190.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders